Clinical and pathological aspects of EBV and KSHV infection

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 885-903

  Ambinder, Richard F ^a   Cesarman, Ethel ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929263033     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.051     Document Type: Chapter

References (191)

1. Ablashi, D. V., Chatlynne, L., Thomas, D. et al. (2000). Lack of sero-logic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma. Blood, 96, 2304-2306.
2. Ablashi, D. V., Chatlynne, L. G., Whitman, J. E., Jr., and Cesarman, E. (2002). Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin. Microbiol. Rev., 15, 439-464.
3. Ahronheim, G. A., Auger, F., Joncas, J. H., Ghibu, F., Rivard, G. E., and Raab-Traub, N. (1983). Primary infection by Epstein-Barr virus presenting as aplastic anemia. N. Engl. J. Med., 309, 313-314.
4. Ambinder, R. F. and Mann, R. B. (1994). Detection and characteriza-tion of Epstein-Barr virus in clinical specimens. Am. J. Pathol., 145, 239-252.
5. Ambinder, R. F., Browning, P. J., Lorenzana, I. et al. (1993). Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood, 81, 462-467.
6. Ambinder, R. F., Robertson, K. D., Moore, S. M., and Yang, J. (1996). Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma. Semin. Cancer Biol., 7, 217-226.
7. Ambinder, R. F., Lee, S., and Curran, W. J. (2003). Phase II inter-group trial of sequential chemotherapy and radiotherapy for AIDS-relatedprimarycentralnervoussystemlymphoma. Can-cer Therapy, 1, 215-221.
8. Anagnostopoulos, I., Hummel, M., and Stein, H. (1995). Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review. Leuk. Lymphoma, 19, 1-12.
9. Andreoni, M., Sarmati, L., Nicastri, E. et al. (2002). Primary human herpesvirus 8. infection in immunocompetent children. J. Am. Med. Assoc., 287, 1295-1300.
10. Antinori, A., De Rossi, G., Ammassari, A. et al. (1999). Value of combined approach with thallium-201 single-photon emis-sion computed tomography and Epstein-Barr virus DNA poly-merase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. J. Clin. Oncol., 17, 554-560.
11. Bacchi, M. M., Bacchi, C. E., Alvarenga, M., Miranda, R., Chen, Y. Y., and Weiss, L. M. (1996). Burkitt's lymphoma in Brazil: Strong association with Epstein-Barr virus. Mod. Pathol., 9, 63-67.
12. Barozzi, P., Luppi, M., Facchetti, F. et al. (2003). Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat. Med., 9, 554-561.
13. Bellos, F., Goldschmidt, H., Dorner, M., Ho, A. D., and Moos, M. (1999). Bone marrow derived dendritic cells from patients with multiple myeloma cultured with three distinct protocols do not bear Kaposi's sarcoma associated herpesvirus DNA. Ann. Oncol., 10, 323-327.
14. Bonnet, M., Guinebretiere, J. M., Kremmer, E. et al. (1999). Detec-tion of Epstein-Barr virus in invasive breast cancers. J. Natl Cancer Inst., 91, 1376-1381.
15. Boulanger, E., Gerard, L., Gabarre, J. et al. (2005). Prognostic fac-tors and outcome of human herpesvirus 8-associated promary effusion lymphoma in patients with AIDS. J. Clin. Oncol., 23, 4372-4380.
16. Brander, C., Raje, N., O'Connor, P. G. et al. (2002). Absence of biolog-ically important Kaposi sarcoma-associated herpesvirus gene products and virus-specific cellular immune responses in mul-tiple myeloma. Blood, 100, 698-700.
17. Brousset, P., Cesarman, E., Meggetto, F., Lamant, L., and Delsol, G. (2001). Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spin-dle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease. Hum. Pathol., 32, 95-100.
18. Camilleri-Broet, S., Davi, F., Feuillard, J. et al. (1997). AIDS-related primary brain lymphomas: Histopathologic and immunohis-tochemical study of 51 cases. The French Study Group for HIV-Associated Tumors. Hum. Pathol., 28, 367-374.
19. Cannon, J. S., Hamzeh, F., Moore, S., Nicholas, J., and Ambinder, R. F. (1999a). Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to gan-ciclovir. J. Virol., 73, 4786-4793.
20. Cannon, J. S., Nicholas, J., Orenstein, J. M. et al. (1999b). Hetero-geneity of viral IL-6 expression in HHV-8-associated diseases. J. Infect. Dis., 180, 824-828.
21. Carbone, A. (2003). Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol., 4, 22-29.
22. Casper, C., Wald, A., Pauk, J., Tabet, S. R., Corey, L., and Celum, C. L. (2002). Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men. J. Infect. Dis., 185, 990-993.
23. Casper, C., Nichols, W. G., Huang, M. L., Corey, L., and Wald, A. (2004). Remission of HHV-8 and HIV-associated multicen-tric Castleman disease with ganciclovir treatment. Blood, 103, 1632-1634.
24. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W., and Knowles, D. M. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med., 332, 1186-1191.
25. Chadburn, A., Suciu-Foca, N., Cesarman, E., Reed, E., Michler, R. E., and Knowles, D. M. (1995). Post-transplantation lymphopro-liferative disorders arising in solid organ transplant recipi-ents are usually of recipient origin. Am. J. Pathol., 147, 1862-1870.
26. Chadburn, A., Chen, J. M., Hsu, D. T. et al. (1998). The morphologic and molecular genetic categories of posttransplantation lym-phoproliferative disorders are clinically relevant. Cancer, 82, 1978-1987.
27. Chadburn, A., Hyjek, E., Mathew, S., Cesarman, E., Said, J. and Knowles, D. M. (2004). KSHV-positive solid lymphomas repre-sent an extra-cavitary variant of primary effusion lymphoma. Am. J. Surg. Pathol., 28, 1401-1416.
28. Chan, A. T., Lo, Y. M., Zee, B. et al. (2002). Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferenti-ated nasopharyngeal carcinoma. J. Natl Cancer Inst., 94, 1614-1619.
29. Chan, A. T., Tao, Q., Robertson, K. D. et al. (2004). Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors in patients. J. Clin. Oncol., 22, 1373-1381.
30. Chan, J. K., Sin, V. C., Wong et al. (1997). Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopatho-logic study of 49 cases of an uncommon aggressive neoplasm. Blood, 89, 4501-4513.
31. Chan, K. C., Zhang, J., Chan, A. T. et al. (2003). Molecular charac-terization of circulating EBV DNA in the plasma of nasopha-ryngeal carcinoma and lymphoma patients. Cancer Res., 63, 2028-2032.
32. Chang, E. T., Zheng, T., Lennette, E. T. et al. (2004). Heterogene-ity of risk factors and antibody profiles in Epstein-Barr virus genome-positive and-negative Hodgkin lymphoma. J. Infect. Dis., 189, 2271-2281.
33. Chang, K. L., Albujar, P. F., Chen, Y. Y., Johnson, R. M., and Weiss, L. M. (1993). High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood, 81, 496-501.
34. Chang, Y., Cesarman, E., Pessin, M. S. et al. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266, 1865-1869.
35. Chatlynne, L. G., Lapps, W., Handy, M. et al. (1998). Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood, 92, 53-58.
36. Cheung, M. M., Chan, J. K., and Wong, K. F. (2003). Natural killer cell neoplasms: A distinctive group of highly aggressive lym-phomas/leukemias. Semin. Hematol., 40, 221-232.
37. Chiang, A. K., Tao, Q., Srivastava, G., and Ho, F. C. (1996). Nasal NK-and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease., Int. J. Cancer, 68, 285-290.
38. Chiou, C. J., Poole, L. J., Kim, P. S. et al. (2002). Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J. Virol., 76, 3421-3439.
39. Chua, D., Huang, J., Zheng, B. et al. (2001). Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma. Int. J. Cancer, 94, 73-80.
40. Clarke, C. A., Glaser, S. A., Dorfman, R. F., et al. (2001). Epstein-Barr virus and survival after Hodgkin's disease in a population-based series of women. Cancer, 91, 1579-1587.
41. Cockerell, C. J. (1991). Histopathological features of Kaposi's sar-coma in HIV infected individuals. Cancer Surv., 10, 73-89.
42. Coffey, A. J., Brooksbank, R. A., Brandau, O. et al. (1998). Host response to EBV infection in X-linked lymphoproliferative dis-ease results from mutations in an SH2-domain encoding gene. Nat. Genet., 20, 129-135.
43. Cohen, J. I. (2000). Epstein-Barr virus infection. N. Engl. J. Med., 343, 481-492.
44. Connolly, Y., Littler, E., Sun, N. et al. (2001). Antibodies to Epstein-Barr virus thymidine kinase: A characteristic marker for the serological detection of nasopharyngeal carcinoma. Int. J. Cancer, 91, 692-697.
45. Cool, C. D., Rai, P. R., Yeager, M. E. et al. (2003). Expression of human herpesvirus 8 in primary pulmonary hypertension. N. Engl. J. Med., 349, 1113-1122.
46. Corbellino, M., Pizzuto, M., Bestetti, G. et al. (1999). Absence of Kaposi's sarcoma-associated herpesvirus DNA sequences in multiple myeloma. Blood, 93, 1110-1111.
47. Corbellino, M., Bestetti, G., Scalamogna, C. et al. (2001). Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood, 98, 3473-3475.
48. Crawford, D. H., Swerdlow, A. J., Higgins, C. et al. (2002). Sexual history and Epstein-Barr virus infection. J. Infect. Dis., 186, 731-736.
49. Cruchley, A. T., Murray, P. G., Niedobitek, G., Reynolds, G. M., Williams, D. M., and Young, L. S. (1997). The expression of the Epstein-Barr virus nuclear antigen (EBNA-I) in oral hairy leukoplakia. Oral Dis., 3(Suppl 1), S177-S179.
50. De Luca, A., Antinori, A., Cingolani, A. et al. (1995). Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lym-phoma. Br. J. Haematol., 90, 844-849.
51. Di Alberti, L., Piattelli, A., and Artese, L. (1997). Human herpesvirus 8 variants in sarcoid tissues. Lancet, 350, 1655-1661.
52. Domachowske, J. B., Cunningham, C. K., Cummings, D. L., Crosley, C. J., Hannan, W. P., and Weiner, L. B. (1996). Acute manifesta-tions and neurologic sequelae of Epstein-Barr virus encephalitis in children. Pediatr. Infect. Dis. J., 15, 871-875.
53. Dominici, M., Luppi, M., Campioni, D. et al. (2000). PCR with degen-erateprimersforhighlyconserved DNApolymerasegeneofthe herpesvirus family shows neither human herpesvirus 8 nor a related variant in bone marrow stromal cells from multiple myeloma patients. Int. J. Cancer, 86, 76-82.
54. Drabick, J. J., Davis, B. J., Lichy, J. H., Flynn, J. and Byrd, J. C. (2002). Human herpesvirus 8 genome is not found in whole bone marrow core biopsy specimens of patients with plasma cell dyscrasias. Ann. Hematol., 81, 304-307.
55. Du, M. Q., Liu, H., Diss, T. C. et al.(2001). Kaposisarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphopro-liferative disorders. Blood, 97, 2130-2136.
56. Dukers, N. H., Renwick, N., Prins, M. et al. (2000). Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am. J. Epidemiol., 151, 213-224.
57. Dupin, N., Fisher, C., Kellam, P. et al. (1999). Distribution of human herpesvirus-8 latently infected cells in Kaposi's sar-coma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. USA, 96, 4546-4551.
58. Dupin, N., Diss, T. L., Kellam, P. et al. (2000). HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood, 95, 1406-1412.
59. Elenitoba-Johnson, K. S. and Jaffe, E. S. (1997). Lymphoprolifera-tive disorders associated with congenital immunodeficiencies. Semin. Diagn. Pathol., 14, 35-47.
60. Engels, E. A., Pittaluga, S., Whitby, D. et al. (2003). Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: A role for Kaposi's sarcoma-associated herpesvirus. Mod. Pathol., 16, 424-429.
61. Epstein, M. A. (2001). Refiections on Epstein-Barr virus: Some recently resolved old uncertainties. J. Infect., 43, 111-115.
62. Faulkner, G. C., Burrows, S. R., Khanna, R., Moss, D. J., Bird, A. G., and Crawford, D. H. (1999). X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: Implications for the biology of the virus. J. Virol., 73, 1555-1564.
63. Feng, W. H., Hong, G., Delecluse, H. J., and Kenney, S. C. (2004). Lytic induction therapy for Epstein-Barr virus positive B-cell lymphomas. J. Virol., 78, 1839-1902.
64. Filipovich, A. H., Mathur, A., Kamat, D., Kersey, J. H., and Shapiro, R. S. (1994). Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency, 5, 91-112.
65. Frank, D., Cesarman, E., Liu, Y. F., Michler, R. E., and Knowles, D. M. (1995). Posttransplantation lymphoproliferative disorders fre-quently contain type A and not type B Epstein-Barr virus. Blood, 85, 1396-1403.
66. Fukayama, M., Chong, J. M., and Kaizaki, Y. (1998). Epstein-Barr virus and gastric carcinoma. Gastric Cancer, 1, 104-114.
67. Gao, S. J., Kingsley, L., Li, M. et al. (1996). KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat. Med., 2, 925-928.
68. Gelb, A. B., van de Rijn, M., Regula, D. P., Jr. et al. (1994). Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum. Pathol., 25, 953-960.
69. Gill, P. S., Tsai, Y. C., Rao, A. P. et al. (1998). Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc. Natl Acad. Sci. USA, 95, 8257-8261.
70. Gilligan, K., Rajadurai, P., Resnick, L., and Raab-Traub, N. (1990). Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc. Natl Acad. Sci. USA, 87, 8790-8794.
71. Glaser, S. L., Lin, R. J., Stewart, S. L. et al. (1997). Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. Int. J. Cancer, 70, 375-382.
72. Glaser, S. L., Ambinder, R. F., DiGiuseppe, J. A., Horn-Ross, P. L., and Hsu, J. L. (1998). Absence of Epstein-Barr virus EBER-1 tran-scripts in an epidemiologically diverse group of breast cancers. Int. J. Cancer, 75, 555-558.
73. Glaser, S. L., Clarke, C. A., Gulley, M. L. et al. (2003). Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Cancer, 98, 300-309.
74. Grose, C., Henle, W., Henle, G., and Feorino, P. M. (1975). Primary Epstein-Barr-virus infections in acute neurologic diseases. N. Engl. J. Med., 292, 392-395.
75. Grufferman, S. and Delzell, E. (1984). Epidemiology of Hodgkin's disease. Epidemiol. Rev., 6, 76-106.
76. Gruhn, B., Meerbach, A., Hafer, R., Zell, R., Wutzler, P., and Zintl, F. (2003). Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation. Bone Marrow Transpl., 31, 1023-1025.
77. Grulich, A. E., Olsen, S. J., Luo, K. et al. (1999). Kaposi's sarcoma-associated herpesvirus: A sexually transmissible infection? J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 20, 387-393.
78. Grulich, A. E., Li, Y., McDonald, A., Correll, P. K., Law, M. G., and Kaldor, J. M. (2002). Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. 16, 1155-1161.
79. Hagihara, M., Tsuchiya, T., Hyodo, O. et al. (2003). Clinical effects of infusing anti-Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic active EBV infection. Int. J. Hematol., 78, 62-68.
80. Hall, P. A., Donaghy, M., Cotter, F. E., Stansfeld, A. G., and Levison, D. A. (1989). An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Histopathology, 14, 333-346; discussion 429-432.
81. Haque, M., Davis, D. A., Wang, V., Widmer, I., and Yarchoan, R. (2003). Kaposi's sarcoma-associated herpesvirus (human her-pesvirus 8) contains hypoxia response elements: Relevance to lytic induction by hypoxia. J. Virol., 77, 6761-6768.
82. Harris, N. L., Ferry, J. A., and Swerdlow, S. H. (1997). Posttrans-plant lymphoproliferative disorders: Summary of Society for Hematopathology Workshop. Semin. Diagn. Pathol., 14, 8-14.
83. Henke, C. E., Kurland, L. T., and Elveback, L. R. (1973). Infectious mononucleosis in Rochester, Minnesota, 1950 through 1969. Am. J. Epidemiol., 98, 483-490.
84. Henke-Gendo, C., Schulz, T. F., and Hoeper, M. M. (2004). HHV-8 in pulmonary hypertension. N. Engl. J. Med., 350, 194-195; author reply 194-195.
85. Henle, W., Henle, G., and Lennette, E. T. (1979). The Epstein-Barr virus. Sci. Am., 241, 48-59.
86. Hislop, A. D., Annels, N. E., Gudgeon, N. H., Leese, A. M., and Rickin-son, A. B. (2002). Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med., 195, 893-905.
87. Hjalgrim, H., Askling, J., Rostgaard, K. et al.(2003). Characteristicsof Hodgkin's lymphoma after infectious mononucleosis. N. Engl. J. Med., 349, 1324-1332.
88. Horenstein, M. G., Nador, R. G., Chadburn, A. et al. (1997). Epstein-Barr virus latent gene expression in primary effu-sion lymphomas containing Kaposi's sarcoma-associated her-pesvirus/human herpesvirus-8. Blood, 90, 1186-1191.
89. Hsu, J. L. and Glaser, S. L. (2000). Epstein-Barr virus-associated malignancies: Epidemiologic patterns and etiologic implica-tions. Crit. Rev. Oncol. Hematol., 34, 27-53.
90. Huang, J., Chen, H., Hutt-Fletcher, L., Ambinder, R. F., and Hay-ward, S. D. (2003). Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. J. Virol., 77, 13267-13274.
91. Isaacson, P. G., Schmid, C., Pan, L., Wotherspoon, A. C., and Wright, D. H. (1992). Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis. J. Pathol., 167, 267-271.
92. Jaffe, E. S., Krenacs, L., Kumar, S., Kingma, D. W., and Raffeld, M. (1999). Extranodal peripheral T-cell and NK-cell neoplasms. Am. J. Clin. Pathol., 111, S46-S55.
93. James, J. A., Neas, B. R., Moser, K. L. et al. (2001). Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum., 44, 1122-1126.
94. Jenson, H. B. (2004). Virologic diagnosis, viral monitoring, and treatment of Epstein-Barr virus infectious mononucleosis. Curr. Infect. Dis. Rep., 6, 200-207.
95. Jia, W. H., Feng, B. J., Xu, Z. L. et al. (2004). Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China. Cancer, 101, 363-369.
96. Kang, I., Quan, T., Nolasco, H. et al. (2004). Defective control of latent Epstein-Barr virus infection in systemic lupus erythe-matosus. J. Immunol., 172, 1287-1294.
97. Katano, H., Sato, Y., Kurata, T., Mori, S., and Sata, T. (1999). High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. Am. J. Pathol., 155, 47-52.
98. Katano, H., Sato, Y., Kurata, T., Mori, S., and Sata, T. (2000). Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology, 269, 335-344.
99. Katano, H., Ali, M. A., Patera, A. C. et al. (2004). Chronic active Epstein-Barr virus infection associated with mutations in per-forin that impair its maturation. Blood, 103, 1244-1252.
100. Kedes, D. H., Operskalski, E., Busch, M., Kohn, R., Flood, J., and Ganem, D. (1996). The seroepidemiology of human her-pesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distri-bution of infection in KS risk groups and evidence for sexual transmission. Nat. Med., 2, 918-924.
101. Kellam, P., Bourboulia, D., Dupin, N. (1999). Characterization of monoclonal antibodies raised against the latent nuclear anti-gen of human herpesvirus 8. J. Virol., 73, 5149-5155.
102. Kelly, G., Bell, A., and Rickinson, A. (2002). Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregula-tion of the nuclear antigen EBNA2. Nat. Med., 8, 1098-1104.
103. Knowles, D. M. (1999). Immunodeficiency-associated lymphopro-liferative disorders. Mod. Pathol., 12, 200-217.
104. Knowles, D. M., Cesarman, E., Chadburn, A. et al. (1995). Cor-relative morphologic and molecular genetic analysis demon-strates three distinct categories of posttransplantation lym-phoproliferative disorders. Blood, 85, 552-565.
105. Koelle, D. M., Huang, M. L., Chandran, B., Vieira, J., Piepkorn, M., and Corey, L. (1997). Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: Clinical and immunologic correlates. J. Infect. Dis., 176, 94-102.
106. Krown, S. E. (2004). Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: Implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma. J. Clin. Oncol., 22, 399-402.
107. Labrecque, L. G., Barnes, D. M., Fentiman, I. S., and Griffin, B. E. (1995). Epstein-Barr virus in epithelial cell tumors: A breast cancer study. Cancer Res., 55, 39-45.
108. Larroche, C., Cacoub, P., Soulier, J. et al. (2002). Castleman's disease and lymphoma: Report of eight cases in HIV-negative patients and literature review. Am. J. Hematol., 69, 119-126.
109. Lebbe, C., Agbalika, F., Flageul, B. et al. (1999). No evidence for a role of human herpesvirus type 8 in sarcoidosis: Molecular and serological analysis. Br. J. Dermatol, 141, 492-496.
110. Lerza, R., Castello, G., Truini, M. et al. (1999). Splenectomy induced complete remission in a patient with multicentric Castleman's disease and autoimmune hemolytic anemia. Ann. Hematol., 78, 193-196.
111. Lever, W. F. and Schaumburg-Lever, G. (1990). Histopathology of the Skin. Philadelphia: Lippincott.
112. Levin, L. I., Munger, K. L., Rubertone, M. V. et al. (2003). Multiple sclerosis and Epstein-Barr virus. J. Am. Med. Assoc., 289, 1533-1536.
113. Lin, C. L., Lo, W. F., Lee, T. H. et al. (2002). Immunization with Epstein-Barr virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyn-geal carcinoma. Cancer Res., 62, 6952-6958.
114. Lin, J. C., Wang, W. Y., Chen, K. Y., Wei, Y. H., Liang, W. M., Jan, J. S. and Jiang, R. S. (2004). Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N. Engl. J. Med., 350, 2461-2470.
115. Ling, P. D., Lednicky, J. A., Keitel, W. A. et al. (2003a). The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: A 14-month longitudinal study. J. Infect. Dis., 187, 1571-1580.
116. Ling, P. D., Vilchez, R. A., Keitel, W. A. et al. (2003b). Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral ther-apy. Clin. Infect. Dis., 37, 1244-1249.
117. Lo, Y. M., Chan, A. T., Chan, L. Y. et al. (2000). Molecular prognosti-cation of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res., 60, 6878-6881.
118. Loren, A. W., Porter, D. L., Stadtmauer, E. A., and Tsai, D. E. (2003). Post-transplant lymphoproliferative disorder: A review. Bone Marrow Transpl., 31, 145-155.
119. Luppi, M., Barozzi, P., Guaraldi, G. et al. (2003). Human herpesvirus 8-associated diseases in solid-organ transplantation: Impor-tance of viral transmission from the donor. Clin. Infect. Dis., 37, 606-607; author reply 607.
120. MacMahon, E. M., Glass, J. D., Hayward, S. D. et al. (1991). Epstein-Barr virus in AIDS-related primary central nervous system lym-phoma. Lancet, 338, 969-973.
121. Maeda, H., Niimi, T., Sato, S. et al. (2000). Human herpesvirus 8 is not associated with sarcoidosis in Japanese patients. Chest, 118, 923-927.
122. Magrath, I. T. (1997). Non-Hodgkin's lymphomas: Epidemiology and treatment. Ann. NY Acad. Sci., 824, 91-106.
123. Marcelin, A. G., Aaron, L., Mateus, C. et al. (2003). Rituximab therapy for HIV-associated Castleman disease. Blood, 102, 2786-2788.
124. Martin, J. N., Ganem, D. E., Osmond, D. H., Page-Shafer, K. A., Macrae, D., and Kedes, D. H. (1998). Sexual transmission and the natural history of human herpesvirus 8 infection. N. Engl. J. Med., 338, 948-954.
125. Martin, D. F., Kuppermann, B. D., Wolitz, R. A., Palestine, A. G., Li, H., and Robinson, C. A. (1990). Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N. Engl. J. Med., 340, 1063-1070.
126. McClain, K. L., Leach, C. T., Jenson, H. B. et al. (1995). Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N. Engl. J. Med., 332, 12-18.
127. McClain, K. L., Leach, C. T., Jenson, H. B. et al. (2000). Molecular and virologic characteristics of lymphoid malignancies in children with AIDS. J. Acquir. Immune Defic. Syndr., 23, 152-159.
128. Menke, D. M., Chadbum, A., Cesarman, E. et al. (2002). Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection. Am. J. Clin. Pathol., 117, 268-275.
129. Milman, G., Scott, A. L., Cho, M. S. et al. (1985). Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man. Proc. Natl. Acad. Sci. USA, 82, 6300-6304.
130. Moore, P. S. (1998). Human herpesvirus 8 variants. Lancet, 351, 679-680.
131. Moore, S. M., Cannon, J. S., Tanhehco, Y. C., Hamzeh, E. M., and Ambinder, R. F. (2001). Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues. Antimicrob. Agents Chemother., 45, 2082-2091.
132. Moss, D. J., Khanna, R., Sherritt, M., Elliott, S. L., and Burrows, S. R. (1999). Developing immunotherapeutic strategies for the con-trol of Epstein-Barr virus-associated malignancies. J. Acquir. Immune Defic. Syndr., 21 Suppl 1, S80-S83.
133. Murray, P. G., Lissauer, D., Junying, J. et al. (2003). Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. Cancer Res., 63, 2338-2343.
134. Nador, R. G., Cesarman, E., Chadburn, A. et al. (1996). Primary effu-sion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood, 88, 645-656.
135. Niederman, J. C., Miller, G., Pearson, H. A., Pagano, J. S., and Dowal-iby, J. M. (1976). Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx. N. Engl. J. Med., 294, 1355-1359.
136. Niedobitek, G., Agathanggelou, A., Rowe, M. et al. (1995). Hetero-geneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood, 86, 659-665.
137. Okano, M. and Gross, T. G. (1996). Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleo-sis. Am. J. Hematol., 53, 111-115.
138. Pan, L., Milligan, L., Michaeli, J., Cesarman, E., and Knowles, D. M. (2001). Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. J. Mol. Diagn, 3, 32-38.
139. Papadopoulos, E. B., Ladanyi, M., Emanuel, D. et al. (1994). Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med., 330, 1185-1191.
140. Parravicini, C., Corbellino, M. et al. (1997). Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castle-man's disease. Am. J. Pathol., 151, 1517-1522.
141. Parravicini, C., Chandran, B., Corbellino, M. et al. (2000). Differ-ential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effu-sion lymphoma, and multicentric Castleman's disease. Am. J. Pathol., 156, 743-749.
142. Pathmanathan, R., Prasad, U., Chandrika, G., Sadler, R., Flynn, K., and Raab-Traub, N. (1995). Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am. J. Pathol., 146, 1355-1367.
143. Pellett, P. E., Spira, T. J., Bagasra, O. et al. (1999). Multicenter com-parison of PCR assays for detection of human herpesvirus 8 DNA in semen. J. Clin. Microbiol., 37, 1298-1301.
144. Penn, I. (1996). Cancers in cyclosporine-treated vs azathioprine-treated patients. Transpl. Proc., 28, 876-878.
145. Porcu, P., Eisenbeis, C. F., Pelletier, R. P. et al. (2002). Successful treatment of posttransplantation lymphoproliferative disor-der (PTLD) following renal allografting is associated with sus-tained CD8(+) T-cell restoration. Blood, 100, 2341-2348.
146. Raab-Traub, N. (2002). Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol., 12, 431-441.
147. Rabkin, C. S., Janz, S., Lash, A. et al. (1997). Monoclonal origin of multicentric Kaposi's sarcoma lesions. N. Engl. J. Med., 336, 988-993.
148. Rea, T. D., Russo, J. E., Katon, W., Ashley, R. L., and Buchwald, D. S. (2001). Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. J. Am. Board Fam. Pract., 14, 234-242.
149. Regamey, N., Erb, P., Tamm, M., and Cathomas, G. (1998). Human herpesvirus 8 variants. Lancet, 351, 680.
150. Rettig, M. B., Ma, H. J., and Vescio, R. A. (1997). Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science, 276, 1851-1854.
151. Reyes, C., Abuzaitoun, O., De Jong, A., Hanson, C., and Langston, C. (2002). Epstein-Barr virus-associated smooth muscle tumors inataxia-telangiectasia: Acasereportandreview. Hum. Pathol., 33, 133-136.
152. Robertson, K. D., Manns, A., Swinnen, L. J., Zong, J. C., Gulley, M. L., and Ambinder, R. F. (1996). CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease. Blood, 88, 3129-3136.
153. Robles, R., Lugo, D., Gee, L., and Jacobson, M. A. (1990). Effect of antiviral drugs used to treat cytomegalovirus end-organ dis-ease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 20, 34-38.
154. Rooney, C. M., Smith, C. A., Ng, C. Y. et al. (1998). Infusion of cyto-toxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood, 92, 1549-1555.
155. Rowe, D. T., Webber, S., Schauer, E. M., Reyes, J., and Green, M. (2001). Epstein-Barr virus load monitoring: Its role in the pre-vention and management of post-transplant lymphoprolifer-ative disease. Transpl. Infect. Dis., 3, 79-87.
156. Roy, M., Bailey, B., Amre, D. K., Girodias, J. B., Bussieres, J. F., and Gaudreault, P. (2004). Dexamethasone for the treatment of sore throat in children with suspected infectious mononucleosis: A randomized, double-blind, placebo-controlled, clinical trial. Arch. Pediatr. Adolesc. Med., 158, 250-254.
157. Said, J. W., Rettig, M. R., Heppner, K. et al. (1997). Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood, 90, 4278-4282.
158. Savoldo, B., Huls, M. H., Liu, Z. et al. (2002). Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood, 100, 4059-4066.
159. Seemayer, T. A., Gross, T. G., Egeler, R. M. et al. (1995). X-linked lym-phoproliferative disease: Twenty-five years after the discovery. Pediatr. Res., 38, 471-478.
160. Sharifi, R., Sinclair, J. C., Gilmour, K. C. et al. (2004). SAP mediates specific cytotoxic T-cell functions in X-linked lymphoprolifer-ative disease. Blood, 103, 3821-3827.
161. Sitki-Green, D. L., Edwards, R. H., Covington, M. M., and Raab-Traub, N. (2004). Biology of Epstein-Barr virus during infec-tious mononucleosis. J. Infect. Dis., 189, 483-492.
162. Smith, N. A., Sabin, C. A., Gopal, R. et al. (1999). Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J. Infect. Dis., 180, 600-606.
163. Soto, N. E. and Straus, S. E. (2000). Chronic fatigue syndrome and herpesviruses: The fading evidence. Herpes, 7, 46-50.
164. Soulier, J., Grollet, L., Oksenhendler, E. et al. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood, 86, 1276-1280.
165. Starzl, T. E., Nalesnik, M. A., Porter, K. A. et al. (1984). Reversibil-ity of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet, 1, 583-587.
166. Staskus, K. A., Sun, R., Miller, G. et al. (1999). Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lym-phoma, and multicentric Castleman's disease. J. Virol., 73, 4181-4187.
167. Straus, S. E. (1993). Studies of herpesvirus infection in chronic fatigue syndrome. Ciba Found. Symp., 173, 132-139; discus-sion 139-145.
168. Suda, T., Katano, H., Delsol, G. et al. (2001). HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castle-man's disease. Pathol. Int., 51, 671-679.
169. Sugaya, M., Nakamura, K., Takahiro, W., and Tamaki, K. (1999). Human herpesvirus type 8 is not detected in cutaneous lesions of sarcoidosis. Br. J. Dermatol., 141, 769.
170. Sumaya, C. V. (1987). Epstein-Barr virus infections in children. Curr. Probl. Pediatr., 17, 677-745.
171. Sumazaki, R., Kanegane, H., Osaki, M. et al. (2001). SH2D1A mutations in Japanese males with severe Epstein-Barr virus-associated illnesses. Blood, 98, 1268-1270.
172. Swerdlow, S. H. (1997). Classification of the posttransplant lympho-proliferative disorders: From the past to the present. Semin. Diagn. Pathol., 14, 2-7.
173. Swigris, J. J., Berry, G. J., Raffin, T. A., and Kuschner, W. G. (2002). Lymphoid interstitial pneumonia: A narrative review. Chest, 122, 2150-2164.
174. Swinnen, L. J. (2001). Organ transplant-related lymphoma. Curr. Treat. Options Oncol., 2, 301-308.
175. Takada, K. (2000). Epstein-Barr virus and gastric carcinoma. Mol Pathol, 53, 255-261.
176. Taketani, T., Kikuchi, A., Inatomi, J. et al. (2002). Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation. Bone Marrow Transpl., 29, 531-533.
177. Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A., and Ambinder, R. F. (1998). Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: Molecular analysis of primary tumor tissue. Blood, 91, 1373-1381.
178. Tao, Q., Yang, J., Huang, H., Swinnen, L. J., and Ambinder, R. F. (2002). Conservation of Epstein-Barr virus cytotoxic T-cell epi-topes in posttransplant lymphomas: Implications for immune therapy. Am. J. Pathol., 160, 1839-1845.
179. Tarte, K., Chang, Y., and Klein, B. (1999). Kaposi's sarcoma-associated herpesvirus and multiple myeloma: Lack of criteria for causality. Blood, 93, 3159-3163; discussion 3163-3164.
180. Torre, D. and Tambini, R. (1999). Acyclovir for treatment of infec-tious mononucleosis: A meta-analysis. Scand. J. Infect. Dis., 31, 543-547.
181. Tosato, G., Magrath, I., Koski, I., Dooley, N., and Blaese, M. (1979). Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. N. Engl. J. Med., 301, 1133-1137.
182. Tynell, E., Aurelius, E., Brandell, A. et al. (1996). Acyclovir and pred-nisolone treatment of acute infectious mononucleosis: A mul-ticenter, double-blind, placebo-controlled study. J. Infect. Dis., 174, 324-331.
183. Van Baarle, D., Wolthers, K. C., Hovenkamp, E. et al., (2002). Absolute level of Epstein-Barr virus DNA in human immun-oDeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. J. Infect. Dis., 186, 405-409.
184. van Gelder, T., Vuzevski, V. D., and Weimar, W. (1995). Epstein-Barr virus in smooth-muscle tumors. N. Engl. J. Med., 332, 1719.
185. Walling, D. M., Flaitz, C. M., and Nichols, C. M. (2003). Epstein-Barr virus replication in oral hairy leukoplakia: Response, persis-tence, and resistance to treatment with valacyclovir. J. Infect. Dis., 188, 883-890.
186. Webster-Cyriaque, J., Middeldorp, J., and Raab-Traub, N. (2000). Hairy leukoplakia: An unusual combination of transforming and permissive Epstein-Barr virus infections. J. Virol., 74, 7610-7618.
187. Wu, T. C., Mann, R. B., Epstein, J. I. et al. (1991). Abun-dant expression of EBER1 small nuclear RNA in nasopha-ryngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am. J. Pathol., 138, 1461-1469.
188. Yang, J., Tao, Q., Flinn, I. W. et al.(2000). Characterizationof Epstein-Barr virus-infected B cells in patients with posttransplanta-tion lymphoproliferative disease: Disappearance after ritux-imab therapy does not predict clinical response. Blood, 96, 4055-4063.
189. Yang, L., Hakoda, M., Iwabuchi, K. et al. (2004). Rheumatoid factors induce signaling from B cells, leading to epstein-barr virus and B-cell activation. J. Virol., 78, 9918-9923.
190. Yao, Y., Minter, H. A., Chen, X., Reynolds, G. M., Bromley, M., and Arrand, J. R. (2000). Heterogeneity of HLA and EBER expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int. J. Cancer, 88, 949-955.
191. Yu, M. C. and Yuan, J. M. (2002). Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol., 12, 421-429.